Vaneck Vectors Pharm (PPH) 59.36 $PPH VanEck to
Post# of 273331
Posted On: 09/25/2016 7:11:09 AM
Vaneck Vectors Pharm (PPH) 59.36 $PPH
VanEck to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Mon Sep 12, 9:00AM CDT
What:
GNRX: 25.29 (+0.01), PPH: 59.36 (-0.03), BBH: 118.57 (-0.60), NDAQ: 69.46 (-0.98)
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 8:30AM CDT
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
Will a Clinton Presidency Spell Doom for Pharma ETFs?
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 2:39PM CDT
While drug pricing controversy continues to weigh on the pharma sector, there are several reasons to take a look at these beaten down ETFs.
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
Pharma ETFs Soaring on Solid Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 11:22AM CDT
Pharma ETFs are in focus in the days ahead on impressive Q2 results.
IHE: 156.22 (+0.32), BIIB: 312.58 (-2.23), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
ETFs to Gain or Lose if Trump Wins Presidential Election
Sweta Killa - Zacks Investment Research - Wed Jun 08, 9:02AM CDT
Many analysts and forecasters believe that the global economy will go into a protracted recession within 18 months and the stock market will drop with Trump's victory.
IHE: 156.22 (+0.32), XAR: 57.97 (-0.16), PPH: 59.36 (-0.03), SPY: 215.99 (-1.19), FXN: 14.57 (-0.31), PJP: 64.35 (-0.14), XOP: 36.15 (-1.01), XHS: 54.91 (-0.48), FCG: 25.16 (-0.70), XPH: 46.91 (+0.35), ITA: 129.45 (-0.36), PPA: 38.66 (-0.19)
Shares of PPH Down 17.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri May 20, 1:48PM CDT
SmarTrend identified a Downtrend for Pharmaceutical HOLDRs Trust (AMEX
PH) on August 21st, 2015 at $69.93. In approximately 9 months, Pharmaceutical HOLDRs Trust has returned 17.58% as of today's recent price of $57.63.
PPH: 59.36 (-0.03)
Follow J.P. Morgan with These Sector ETFs
Zacks Equity Research - ZACKS - Tue May 10, 1:30AM CDT
Believe in J.P. Morgan? Invest in these sector ETFs.
NFLX: 95.94 (+0.11), PPH: 59.36 (-0.03), IYH: 153.01 (-0.53), IBM: 154.98 (-1.13), PJP: 64.35 (-0.14), XLK: 47.49 (-0.42), GOOGL: 814.96 (-0.99), MSFT: 57.43 (-0.39), SKYY: 33.86 (-0.24), AAPL: 112.71 (-1.91)
Solid Q1 Earnings Fail to Boost Pharma ETFs
Sweta Killa - Zacks Investment Research - Fri May 06, 10:12AM CDT
The string of earnings beat and upbeat outlook failed to boost pharma stocks and ETFs as the industry is grappling with drug pricing issues.
IHE: 156.22 (+0.32), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
Pharma ETFs Outlook -- Drug Pricing Issues Remain in Focus
Zacks Equity Research - Zacks Investment Research - Wed May 04, 1:50PM CDT
what lies ahead for Pharma ETFs in 2016?
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
String of Q4 Earnings Beat Fails to Revive Pharma ETFs
Sweta Killa - Zacks Investment Research - Fri Feb 05, 8:20AM CST
Despite the string of earnings beat, pharma stocks are suffering from the broad healthcare sector concerns.
IHE: 156.22 (+0.32), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
VanEck to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Mon Sep 12, 9:00AM CDT
What:
GNRX: 25.29 (+0.01), PPH: 59.36 (-0.03), BBH: 118.57 (-0.60), NDAQ: 69.46 (-0.98)
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 8:30AM CDT
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
Will a Clinton Presidency Spell Doom for Pharma ETFs?
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 2:39PM CDT
While drug pricing controversy continues to weigh on the pharma sector, there are several reasons to take a look at these beaten down ETFs.
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
Pharma ETFs Soaring on Solid Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 11:22AM CDT
Pharma ETFs are in focus in the days ahead on impressive Q2 results.
IHE: 156.22 (+0.32), BIIB: 312.58 (-2.23), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
ETFs to Gain or Lose if Trump Wins Presidential Election
Sweta Killa - Zacks Investment Research - Wed Jun 08, 9:02AM CDT
Many analysts and forecasters believe that the global economy will go into a protracted recession within 18 months and the stock market will drop with Trump's victory.
IHE: 156.22 (+0.32), XAR: 57.97 (-0.16), PPH: 59.36 (-0.03), SPY: 215.99 (-1.19), FXN: 14.57 (-0.31), PJP: 64.35 (-0.14), XOP: 36.15 (-1.01), XHS: 54.91 (-0.48), FCG: 25.16 (-0.70), XPH: 46.91 (+0.35), ITA: 129.45 (-0.36), PPA: 38.66 (-0.19)
Shares of PPH Down 17.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri May 20, 1:48PM CDT
SmarTrend identified a Downtrend for Pharmaceutical HOLDRs Trust (AMEX
PH) on August 21st, 2015 at $69.93. In approximately 9 months, Pharmaceutical HOLDRs Trust has returned 17.58% as of today's recent price of $57.63. PPH: 59.36 (-0.03)
Follow J.P. Morgan with These Sector ETFs
Zacks Equity Research - ZACKS - Tue May 10, 1:30AM CDT
Believe in J.P. Morgan? Invest in these sector ETFs.
NFLX: 95.94 (+0.11), PPH: 59.36 (-0.03), IYH: 153.01 (-0.53), IBM: 154.98 (-1.13), PJP: 64.35 (-0.14), XLK: 47.49 (-0.42), GOOGL: 814.96 (-0.99), MSFT: 57.43 (-0.39), SKYY: 33.86 (-0.24), AAPL: 112.71 (-1.91)
Solid Q1 Earnings Fail to Boost Pharma ETFs
Sweta Killa - Zacks Investment Research - Fri May 06, 10:12AM CDT
The string of earnings beat and upbeat outlook failed to boost pharma stocks and ETFs as the industry is grappling with drug pricing issues.
IHE: 156.22 (+0.32), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
Pharma ETFs Outlook -- Drug Pricing Issues Remain in Focus
Zacks Equity Research - Zacks Investment Research - Wed May 04, 1:50PM CDT
what lies ahead for Pharma ETFs in 2016?
IHE: 156.22 (+0.32), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), XPH: 46.91 (+0.35)
String of Q4 Earnings Beat Fails to Revive Pharma ETFs
Sweta Killa - Zacks Investment Research - Fri Feb 05, 8:20AM CST
Despite the string of earnings beat, pharma stocks are suffering from the broad healthcare sector concerns.
IHE: 156.22 (+0.32), JNJ: 118.81 (-0.65), PPH: 59.36 (-0.03), PJP: 64.35 (-0.14), MRK: 62.96 (-0.06), PFE: 34.26 (+0.11), XPH: 46.91 (+0.35), LLY: 81.16 (-0.13), BMY: 56.48 (+0.06)
(0)
(0)